CoQsource™ CoQ10

“Patented Absorption Technology 2.0”

CoQsource is a patented and proprietary form of CoQ10 that uses the VesiSorb® delivery system to achieve improved absorption. With CoQsource, peak absorption of 16.97% was achieved in a clinical study. This represents a significant improvement compared to reported peak absorption values of 2.15%, 3.34%, and 5.44% for CoQ10 in powder, oil dispersion, and lipid solution delivery systems respectively. This compelling data is evidence of the benefits this application technology delivers. The following illustration vividly depicts the superiority of the VesiSorb delivery system over competing delivery systems in a relative peak absorption comparison.

SAFETY

All components of CoQsource meet the highest standards of potency, purity and safety, and are comprehensively recognized by the most prestigious scientific compendiums worldwide such as:

• The United States Pharmacopoeia / National Formulary (USP/NF)
• The European Pharmacopoeia
• The Society of Japanese Pharmacopoeia (SJP)

Each excipient and active component is recognized and listed by these bodies as safe and approved, and all materials are produced under GMP conditions in accordance with all regulatory guidelines.

The components in CoQsource have been established and recognized as Generally Regarded as Safe (GRAS) per FDA’s Code of Federal Regulations (CFR 21) and European regulatory standards which guarantees the wholesomeness and safety of each ingredient for human consumption. GRAS is one of four legal categories set up by Congress under the 1958 Food Additives Amendment to the Federal Food, Drug, and Cosmetic Act (FD&C Act). A GRAS substance is defined as one that has a long, safe history of common use in foods, or that is determined to be safe based on proven science. Essentially, it is FDA’s assurance that all ingredients used in food products have undergone extensive toxicological and safety testing to guarantee their safe use in foods.

Examples of CAS (Chemical Abstract registry numbers) have been provided to clearly elucidate the chemical form and structure of each ingredient used in CoQsource for transparency and full disclosure.

SUMMARY / CONCLUSION

The need for supplementing with CoQ10 is clear and has never been greater, especially with the dramatic increase in the number of people taking statin drugs. “It is well established that statins (also known as HMG-CoA Reductase Inhibitor) lower cholesterol by blocking cholesterol synthesis. However it also blocks CoQ10 production. Some people taking statin drugs report a wide range of side effects including muscle pain, weakness, fatigue, memory problem and erectile dysfunction. The side effects could be attributed to the depletion of CoQ10 by statin drugs,” says Dr. Julian M. Whitaker, Director of the Whitaker Wellness Institute and Editor of Health and Healing newsletter.

Lipid lowering drugs (statins) have been shown to deplete CoQ10 from the body. If you are currently taking a cholesterol lowering drug, you should consult with your healthcare professional about the benefits of supplementing with CoQ10.
– FDA Structure Function Claim

The importance of improving uptake and absorption is also quite evident. Not only is CoQsource CoQ10 association colloid system the newest, patented application technology, but the case for the safety of the system for improving absorption is quite remarkable. You might say in the same way the human body is remarkable. This system mirrors the human mixed micellular transport system, and is a safe and efficient approach to improve fat absorption. It is important to reiterate that all of the components used in CoQsource are recognized by the most reputable international pharmaceutical compendiums such as USP/NF, EP and JP. All materials are produced under GMP conditions in accordance with all regulatory guidelines. Further, the components have been recognized as Generally Regarded as Safe (GRAS) for human consumption by internationally recognized bodies.

The time is right to embrace the opportunity and together drive the market to this solution, CoQsource, a patented and proprietary formula designed to support the cardiovascular system, the function of the mitochondria, reduced production of free radicals, energy levels, and stamina and endurance. We offer CoQsource ubiquinone or ubiquinol in both soft gelatin capsule and two piece liquid hard capsules. Both CoQsource products are available in 20% CoQ10 potency which no other “bio-enhanced” technology is capable of delivering. Imagine a 500mg capsule with 100mg of CoQsource with the dramatic improvement in absorption demonstrated in the clinical study. Truly – PATENTED COQ10 ABSORPTION TECHNOLOGY 2.0.

About SourceOne

Anti-Spam Policy

In absence of any other policy, SourceOne™ Global Partners has adopted the Anti-Spam and privacy policy of its hosting provider, WebApplica, Inc.

Spam is absolutely prohibited by WebApplica, Inc clients. WebApplica, Inc and all sites on the CoolerServer Platform (CSP) support ONLY permission-based email marketing practices using the CSP or affiliated partner sites. In this regard, WebApplica, Inc has implemented some of the strictest policies in the email industry and supporting procedures that:

• Help prevent the ByInviteOnly system from being used for the purpose of unsolicited email campaigns.
• Encourage permission-based marketing.
• Respond to all complaints suggesting the CSP or affiliated partner sites have been used as a vehicle to send unsolicited email.

WebApplica, Inc actively monitors import lists and outgoing emails for suspiciously large intended or actual broadcasts. Any customer found to be using the CSP or affiliated partner sites for Spam is subject to being permanently barred from ever using CSP or affiliated partner sites systems.

Spam is unsolicited commercial email, junk mail or bulk mail that has not been requested by the recipient. In addition to wasting valuable resources and time, it is intrusive, irrelevant and often offensive, Typically, spam emails do not contain an option to unsubscribe from the mailing list. Spam is the opposite of permission-based emails ---- those that are anticipated, personal, relevant and often associated with a "pre-existing business or personal relationship."

Preventing Unsolicited Emails Via the CSP or affiliated partner sites system

Users of the CSP or affiliated partner sites must abide by a strictly enforced End User License Agreement. Under this agreement, the user promises to not abuse the CSP or affiliated partner sites system or to send spam. User specifically agrees not to send unsolicited bulk email, for commercial or non-commercial purposes (unsolicited bulk email is defined as email sent to more than 10 individuals without their permission). The agreement also includes such provisions as:

User agrees not to post, upload or otherwise transmit:

• any content related to inappropriate subject matters;
• any content to "rented" or "purchased" lists;
• any content that is unlawful, harmful, threatening, abusive, harassing, tortious, defamatory, vulgar, obscene, libelous, invasive of another's privacy, hateful, or racially, ethnically or otherwise objectionable;
• any content that you do not have a right to post and transmit under any law or contractual/fiduciary relationships;
• any content, such that such posting, uploading, or transmission constitutes the infringement of any patent, trademark, trade secret, copyright or other proprietary rights of any party;
• any materials that contain software viruses or any other computer code, files or programs designed to interrupt, destroy or limit the functionality of any computer software or hardware or telecommunications equipment;
• any materials which imposes an unreasonable large load on our infrastructure;
• any content that is harmful to minors;
• content that intentionally or unintentionally violates any applicable local, state, national or international law, including, but not limited to, regulations promulgated by the U.S. Securities Exchange Commission, any rules of national or other securities exchange, including without limitation, the New York Stock Exchange, the American Stock Exchange or the NASDAQ, and any regulations having the force of law;
• content that is misleading or impersonates any person or entity or falsely states or otherwise misrepresents your affiliation with a person or entity;
• content with manipulated, or forged identifiers;
• content promoting harm or providing instructional information about illegal activities;

With regard to email campaigns, all users of CSP or affiliated partner sites must also accept that an unsubscribe option will be automatically appended to every email sent to more than 100 people via the CSP or affiliated partner sites. This is mandatory. When the unsubscribe option is requested by an email recipient, the CSP or affiliated partner sites system automatically suppresses emails to that email address in future campaigns. This suppression feature is also mandatory.

In the event that a CSP system User violates any one of our usage rules on the CSP or affiliated partner sites, or for any other reason deemed appropriate by WebApplica, Inc or affiliated partner sites, WebApplica, Inc reserves the right to suspend or terminate, without notice, access to the CSP or affiliated partner sites system User's account and all related data. We rely on feedback from various governmental and industry sources, a network of the leading ISP's in the world and millions of email recipients to assist in our policing against spam. If you send an email out through the CSP or affiliated partner sites that generates a spam complaint, you will be responsible for providing an opt-in record for the complaint at issue. Any spam complaints that are not successfully appealed are assessed a $75 fine. Additional fines may be assesed by affiliate partner sites

Permission-Based Marketing

The CSP and/or affiliated partner sites offers frees tools to encourage system Users to create and manage "opt-in" (and double opt-in) lists of contacts. By building and using an "opt-in" (and double opt-in) lists, system Users can be certain that they are sending emails to recipients that have expressly given their permission to do so.

Recommended Action --- Unsolicited Email Complaints

If a complaint is received by WebApplica, Inc regarding alleged unsolicited emails being sent from our system tools, an immediate investigation is undertaken.

Warning -- The system User is notified that an unsolicited email complaint has been lodged against them and a demand is issued to "show proof" that the complainant opted in to the User's list. The User is reminded of the terms they accepted in the End User License Agreement (including possible legal ramifications if the user has is guilty of spamming). In addition, the complainant's email address is automatically tagged as "unsubscribed" if the complainant did unsubscribe--so no further emails are sent to the complainant. The User is also required to manually remove the complainant's email address from their contact list if the complainant did not unsubscribe.

Termination---If WebApplica, Inc or affiliated partner sites have ANY reason to believe the User, despite the warnings, is or will continue to send unsolicited bulk email to more than 10 individuals without their permission, or any complainant who has previously unsubscribed, the User's ByInviteOnly account privileges are subject to immediate termination.

Think You've Been Spammed?

1. Immediately unsubscribe using the "unsubscribe" link at the bottom of the email.
2. Forward the unsolicited email to abuse@webapplica.com and provide any other information that you believe may help us in our investigation.

WebApplica, Inc and partners take permission marketing very seriously. Thank you for reviewing our Anti-Spam Policy.

Many spam complaints are registered with anti-spam agencies. We fully support the efforts of agencies working to responsibly curtail the sending of unsolicited commercial email. However, if an individual opted-in to receive an email and then falsely and/or maliciously files a spam complaint against WebApplica, Inc or affiliated partner sites, we will cooperate fully with appropriate agencies to ban the user from further use of anti-spam software and community.

This policy was last updated: January 1, 2006. We reserve the right to modify this policy at any time.

Contact Us

If you have any questions about this Anti-Spam Policy, Our Privacy Statement, or WebApplica, Inc., developer of the CoolerServer Platform and Internet Marketing Application (IMA®) please contact us directly at: (612) 235-4363, via email at sales@webapplica.com or visit us online at http://www.webapplica.com.

Cardio E® Naturally Balanced E Isomers

Cardio E® Naturally Balanced E Isomers provide 30 I.U. of alpha tocopherol in a 9:1 tocopherol to tocotrienol ration as found in nature.  Cardio E provides low alpha content that does not reduce plasma levels of gamma tocopherol like other commercial vitamin E products, and features high gamma tocopherol.  More specifically, the needs in the natural vitamin E market are as follow:

• Lower alpha-tocopherol levels
• Increase gamma-tocopherol levels
• Add TocoSource Palm Tocotrienols
• Develop vitamin E formulas that mirror our food and have the “appropriate spectrum” of all 8 vitamin E isomers

Chondroitin Sulfate

Company Bios

Contact Us